+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 75Years
All Genders
ID06385236

Study of Genetic and Biological Responses to Two Biologic Treatments in Adults with Moderate to Severe Asthma

Led by University of California, San Diego · Updated on 2024-08-19

120

Participants Needed

3

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating how two approved biologic therapies, Dupilumab and Benralizumab, work for adults with moderate to severe asthma. The study aims to understand each patients unique response to these treatments by using genomic and biological measurements from blood and tissue samples. This approach could improve how asthma treatments are personalized and help predict which patients will benefit the most. The study includes two treatment options given in a random order Dupilumab, which is given as an initial 600 mg dose via two injections followed by 300 mg every two weeks, and Benralizumab, given as a 30 mg injection every four weeks. Participants may also choose to use Symbicort as their controller medication. These treatments are part of standard care and not experimental drugs. The study involves detailed evaluations before and after each therapy, including advanced genetic testing. Participants will be closely monitored over about 60 weeks with regular assessments of asthma control, quality of life, lung function, and biological responses to the treatments. Researchers will use questionnaires and lung tests throughout the study to track changes and predict treatment outcomes. Safety will be monitored continuously to ensure participant well-being during the study period.

CONDITIONS

Brief Title

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Research Team

C

Clinical Trial Operations and Data Management Specialist UA-DCC

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here